Home >> Current Pharmaceutical Design, Volume 13, Number 20
Current Pharmaceutical Design logo Bentham Science Publishers logo

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Related content
Volume 13, Number 20, July 2007

< previous issue | all issues | next issue >

Articles

Editorial [Hot Topic: Angiogenesis and Anti-Angiogenesis (Executive Editor: Maurizio Botta)]
pp. 2024-2024(1)
Author: Maurizio Botta,

Fibroblast Growth Factors/Fibroblast Growth Factor Receptors as Targets for the Development of Anti-Angiogenesis Strategies
pp. 2025-2044(20)
Authors: M. Rusnati,; M. Presta,

Interaction of Heparins with Fibroblast Growth Factors: Conformational Aspects
pp. 2045-2056(12)
Authors: Marco Guerrini,; Milos HricovIni,; Giangiacomo Torri,

Heparanase: Structure, Biological Functions, and Inhibition by Heparin-Derived Mimetics of Heparan Sulfate
pp. 2057-2073(17)
Authors: Israel Vlodavsky,; Neta Ilan,; Annamaria Naggi,; Benito Casu,

Developing Antiangiogenic Peptide Drugs for Angiogenesis-Related Diseases
pp. 2074-2086(13)
Authors: K.N. Sulochana,; R. Ge,

Matrix Metalloproteinase Inhibitors: New Challenges in the Era of Post Broad-Spectrum Inhibitors
pp. 2087-2100(14)
Authors: Elisa Nuti,; Tiziano Tuccinardi,; Armando Rossello,

Free Content Chondromodulin-I and Tenomodulin: The Negative Control of Angiogenesis in Connective Tissue
pp. 2101-2112(12)
Authors: Chisa Shukunami,; Yuji Hiraki,

Regulation of Angiogenesis and Angiogenic Factors by Cardiovascular Medications
pp. 2113-2117(5)
Authors: Shin-ichiro Miura,; Keijiro Saku,

< previous issue | all issues | next issue >

Marked list

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page